
Chris E. Simmons
Examiner (ID: 15486, Phone: (571)272-9065 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1622, 1612 |
| Total Applications | 893 |
| Issued Applications | 268 |
| Pending Applications | 93 |
| Abandoned Applications | 545 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5834177
[patent_doc_number] => 20060246007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Use of osmolytes obtained from extremophilic bacteria the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising an osmolyte as active agent component'
[patent_app_type] => utility
[patent_app_number] => 10/563587
[patent_app_country] => US
[patent_app_date] => 2004-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2444
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246007.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563587 | Use of osmolytes obtained from extremophilic bacteria the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising an osmolyte as active agent component | Jul 1, 2004 | Abandoned |
Array
(
[id] => 5189191
[patent_doc_number] => 20070167500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Remedy for urinary tract diseases'
[patent_app_type] => utility
[patent_app_number] => 10/562126
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17160
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167500.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562126
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562126 | Remedy for urinary tract diseases | Jun 24, 2004 | Abandoned |
Array
(
[id] => 7011438
[patent_doc_number] => 20050065154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Treatment of migraine accompanied by nausea with a combination of cyclooxygenase-2 selective inhibitors and anti-nausea agents'
[patent_app_type] => utility
[patent_app_number] => 10/875940
[patent_app_country] => US
[patent_app_date] => 2004-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23348
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20050065154.pdf
[firstpage_image] =>[orig_patent_app_number] => 10875940
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/875940 | Treatment of migraine accompanied by nausea with a combination of cyclooxygenase-2 selective inhibitors and anti-nausea agents | Jun 23, 2004 | Abandoned |
Array
(
[id] => 7163257
[patent_doc_number] => 20050085452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Process for the synthesis of pharmacologically active (z/e)-guggulsterones'
[patent_app_type] => utility
[patent_app_number] => 10/498316
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1282
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20050085452.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498316
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498316 | Process for the synthesis of pharmacologically active (z/e)-guggulsterones | Jun 9, 2004 | Abandoned |
Array
(
[id] => 133091
[patent_doc_number] => 07696244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-13
[patent_title] => 'Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/556195
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 19
[patent_no_of_words] => 18740
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/696/07696244.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556195
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556195 | Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof | May 13, 2004 | Issued |
Array
(
[id] => 7068968
[patent_doc_number] => 20050244351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Cosmetic compositions with interpenetrating polymer network'
[patent_app_type] => utility
[patent_app_number] => 10/837948
[patent_app_country] => US
[patent_app_date] => 2004-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11857
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244351.pdf
[firstpage_image] =>[orig_patent_app_number] => 10837948
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/837948 | Cosmetic compositions with interpenetrating polymer network | May 2, 2004 | Abandoned |
Array
(
[id] => 7456583
[patent_doc_number] => 20040197285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Sunscreens based on substituted hydrocarbyl functional siloxanes for household, health, and personal care applications'
[patent_app_type] => new
[patent_app_number] => 10/827478
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5286
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20040197285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10827478
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/827478 | Sunscreens based on substituted hydrocarbyl functional siloxanes for household, health, and personal care applications | Apr 18, 2004 | Abandoned |
Array
(
[id] => 7467703
[patent_doc_number] => 20040167034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Emulsion and dispersion formulations and method'
[patent_app_type] => new
[patent_app_number] => 10/478155
[patent_app_country] => US
[patent_app_date] => 2004-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9877
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167034.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478155
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478155 | Emulsion and dispersion formulations and method | Apr 12, 2004 | Abandoned |
Array
(
[id] => 7423772
[patent_doc_number] => 20040265381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma'
[patent_app_type] => new
[patent_app_number] => 10/492070
[patent_app_country] => US
[patent_app_date] => 2004-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6485
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10492070
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/492070 | Anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma | Apr 6, 2004 | Abandoned |
Array
(
[id] => 5683571
[patent_doc_number] => 20060199841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Pharmaceutical combination for the treatment of spasticity and/or pain'
[patent_app_type] => utility
[patent_app_number] => 10/551510
[patent_app_country] => US
[patent_app_date] => 2004-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3386
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20060199841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551510
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551510 | Pharmaceutical combination for the treatment of spasticity and/or pain | Apr 6, 2004 | Abandoned |
Array
(
[id] => 7020248
[patent_doc_number] => 20050222267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Solution based methacholine formulations'
[patent_app_type] => utility
[patent_app_number] => 10/814633
[patent_app_country] => US
[patent_app_date] => 2004-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12075
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222267.pdf
[firstpage_image] =>[orig_patent_app_number] => 10814633
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/814633 | Solution based methacholine formulations | Mar 31, 2004 | Abandoned |
Array
(
[id] => 6957980
[patent_doc_number] => 20050214350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Antimicrobial sheets for environmental and human protection and prevention'
[patent_app_type] => utility
[patent_app_number] => 10/815197
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 1373
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214350.pdf
[firstpage_image] =>[orig_patent_app_number] => 10815197
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/815197 | Antimicrobial sheets for environmental and human protection and prevention | Mar 28, 2004 | Abandoned |
Array
(
[id] => 5051911
[patent_doc_number] => 20070032456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Modulation of cell death'
[patent_app_type] => utility
[patent_app_number] => 10/551302
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11149
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032456.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551302
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551302 | Modulation of cell death | Mar 24, 2004 | Abandoned |
Array
(
[id] => 7250135
[patent_doc_number] => 20040258771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Reduced toxicity cisplatin formulations and methods for using the same'
[patent_app_type] => new
[patent_app_number] => 10/803458
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5895
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20040258771.pdf
[firstpage_image] =>[orig_patent_app_number] => 10803458
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/803458 | Reduced toxicity cisplatin formulations and methods for using the same | Mar 16, 2004 | Abandoned |
Array
(
[id] => 7265058
[patent_doc_number] => 20040242594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Prodrugs of antidepressants and their use for treating depressions'
[patent_app_type] => new
[patent_app_number] => 10/489657
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6044
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242594.pdf
[firstpage_image] =>[orig_patent_app_number] => 10489657
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/489657 | Prodrugs of antidepressants and their use for treating depressions | Mar 14, 2004 | Abandoned |
Array
(
[id] => 7347353
[patent_doc_number] => 20040192730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Methods of using compounds with combined 5-HT1A and SSRI activities as-needed to treat sexual dysfunction'
[patent_app_type] => new
[patent_app_number] => 10/799490
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22835
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 1480
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192730.pdf
[firstpage_image] =>[orig_patent_app_number] => 10799490
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/799490 | Methods of using compounds with combined 5-HT1A and SSRI activities as-needed to treat sexual dysfunction | Mar 11, 2004 | Abandoned |
Array
(
[id] => 6971262
[patent_doc_number] => 20050036972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'System for managing pathogens and irritants and monitoring usage of anti-bacterial formulations'
[patent_app_type] => utility
[patent_app_number] => 10/797850
[patent_app_country] => US
[patent_app_date] => 2004-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 8097
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20050036972.pdf
[firstpage_image] =>[orig_patent_app_number] => 10797850
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/797850 | System for managing pathogens and irritants and monitoring usage of anti-bacterial formulations | Mar 9, 2004 | Abandoned |
Array
(
[id] => 5815094
[patent_doc_number] => 20060084703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Injectable liquid formulation of paracetamol'
[patent_app_type] => utility
[patent_app_number] => 10/545685
[patent_app_country] => US
[patent_app_date] => 2004-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2512
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10545685
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/545685 | Injectable liquid formulation of paracetamol | Feb 15, 2004 | Issued |
Array
(
[id] => 7411553
[patent_doc_number] => 20040176467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Method of preventing or reducing the occurrence of symptoms of psychosis'
[patent_app_type] => new
[patent_app_number] => 10/486593
[patent_app_country] => US
[patent_app_date] => 2004-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6230
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176467.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486593
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486593 | Method of preventing or reducing the occurrence of symptoms of psychosis | Feb 8, 2004 | Abandoned |
Array
(
[id] => 5924460
[patent_doc_number] => 20060241130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Anti-inflammatory compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/543590
[patent_app_country] => US
[patent_app_date] => 2004-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 35919
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20060241130.pdf
[firstpage_image] =>[orig_patent_app_number] => 10543590
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/543590 | Anti-inflammatory compositions and uses thereof | Jan 31, 2004 | Abandoned |